DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE
About
DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE is used for the treatment of HIV-1 infection in adults and children above 12 years weighing at least 40kgs. HIV is a virus that attacks the body's immune system, making it compromised and susceptible to various infections and diseases.
DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE contains 'Dolutegravir, Emtricitabine and Tenofovir alafenamide'. DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE works by interfering with the work of HIV-1 reverse transcriptase enzymes, which are necessary for the replication of the virus. Together, DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE helps in treating HIV infection.
Take DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE as prescribed. In some cases, DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE may cause certain side effects such as trouble sleeping, headache, nausea, and tiredness. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if these side effects persist.
Consult your doctor if you are pregnant, or planning to get pregnant. Avoid breastfeeding while taking DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE. DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE does not help reduce the risk of getting HIV-1 infection by sexual contact; therefore, it is important to practise safe sex to avoid transmitting HIV to your partner. Avoid alcohol consumption while on treatment with DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE.
Uses of DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE
Medicinal Benefits
DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE is an anti-retroviral drug used in the treatment of HIV-1 infection. DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE works by interfering with the replication of HIV and preventing its further progression. It contains Dolutegravir, Emtricitabine and Tenofovir alafenamide. Dolutegravir works by blocking HIV integrase, which is responsible for integrating viral DNA into the host cell. Thus, it inhibits the integration of the viral component into the human body cells. Emtricitabine works by inhibiting reverse transcriptase, which is responsible for transcribing RNA to DNA. By blocking this action, emtricitabine prevents the proliferation of the virus. Tenofovir alafenamide blocks the enzyme polymerase, thereby preventing aggregation of viral components and terminating the DNA chain, thus effectively nipping viral replication in the bud.
Directions for Use
Storage
Side Effects of DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE
- Headache
- Tiredness
- Trouble sleeping
- Nausea
In-Depth Precautions and Warning
Drug Warnings
Inform the doctor if you are allergic to any of the components of DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE. Consult your doctor if you are pregnant, or planning to get pregnant before taking DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE. Avoid breastfeeding while on treatment with DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE. Avoid alcohol consumption. It is important to practise safe sex to avoid transmitting HIV to your partner. Inform your doctor if you have liver problems, hepatitis infections, heart or kidney problems. Keep your doctor informed about your health condition and medications to rule out any interactions.
Drug Interactions
Drug-Drug Interactions: DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE may interact with antiviral/anti-HIV drug (adefovir dipivoxil, atazanavir, bictegravir, lamivudine), anti-Tb drug (rifampicin), antidepressant (St John’s wort), ulcer medicine (sucralfate), antibiotics (azithromycin, clarithromycin, rifabutin), immunosuppressants (cyclosporine), anti-epileptics (phenobarbital or phenytoin), antacids, iron supplements and vitamins.
Drug-Food Interactions: No interactions found.
Drug-Disease Interactions: DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE should be used with caution in patients with a known hypersensitivity disorder, diabetes, hypertension, hepatitis, liver disease, kidney disease and/or heart disease.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
unsafeIt is not recommended to consume alcohol with DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE. Please consult your doctor if you have any concerns.
Pregnancy
cautionPlease consult your doctor if you are pregnant. Your doctor will prescribe if the benefits are found to outweigh the risks.
Breast Feeding
unsafeAvoid breastfeeding while on treatment with DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE.
Driving
cautionDOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE may cause dizziness and tiredness. Do not drive if you experience any side effects after using DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE.
Liver
cautionExercise caution before using DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE in case of established liver disease. Please consult your doctor to address any concerns.
Kidney
cautionExercise caution before using DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE in case of established kidney disease. Please consult your doctor to address any concerns.
Children
unsafeDOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE is not recommended for use in children under 12 years of age. Please consult your doctor in case of any concerns.
Habit Forming
Diet & Lifestyle Advise
Practise safe sex to prevent transmitting HIV to your partner. Educate yourself and your partner about pre and post-exposure prophylaxis and ART (anti-retroviral therapy). Use a condom as far as possible.
Meditation and yoga have also proven very effective in helping HIV patients maintain a healthy attitude and body.
Eat more lean meats, healthy fats, fruits, vegetables and whole-grain foods.
Take good care of your oral hygiene. HIV often affects the mouth and causes sores. See a dentist regularly. Brush, floss and scrape your tongue well and keep your mouth clean.
Taking a stroll in the garden, or spending 30 minutes of your time doing some light physical activity can be very useful. However, do not over-exert yourself if you feel too tired.
Patients Concern
Disease/Condition Glossary
HIV infection: HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system and destroys the white blood cells that help fight infection, making the individual susceptible to other infections or illnesses. People with HIV experience flu-like symptoms such as fever, chills, rash, night sweats, muscle aches, tiredness, and sore throat. These symptoms usually last for days to several weeks. HIV spreads through body fluids such as semen, vaginal fluid, and blood. If left untreated, this condition can lead to AIDS (Acquired Immunodeficiency Syndrome). It is a life-long condition, and there is no definite cure for it. However, it can be controlled by treating it with antiretroviral drugs.
FAQs
DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE is indicated for the treatment of HIV-1 infection.
DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE works by inhibiting the replication of viral DNA and by preventing it from being integrated into the human body. Thereby, DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE helps treat HIV infection.
It is not known if DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE is safe for patients who have HIV-1 and hepatitis-B infections. Please consult your doctor for any concerns.
Do not stop taking DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE without consulting your doctor as it may reduce the effectiveness of anti-HIV therapy. Continue taking DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE for as long as your doctor has prescribed it to you to treat your condition effectually. Do not be reluctant to speak with your doctor if you experience any difficulty while taking DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE.
DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE might cause lactic acidosis (excess of lactic acid in the blood). Consult a doctor immediately if you experience stomach pain, vomiting, nausea, drowsiness, or deep rapid breathing.
Take the missed dose as soon as you remember, unless it's almost time for your next dose. In this case, skip the missed dose and take your next dose at the regular time. Never take a double dose to make up for a missed one.
Avoid nursing while receiving DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE therapy. Avoid alcohol consumption. It is critical to engage in safe sex to avoid transferring HIV to your partner.
Before taking the DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE, let your doctor know about all your medical conditions, sensitivities, and all the medications you are using. And inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Yes, DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE is an anti-retroviral drug used in the treatment of HIV-1 infection.
The duration of treatment depends on including medical condition and response to the treatment.
The recommended dosage of DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE is one tablet taken orally once daily. But dosage may vary depending on various factors including medical condition and response to the treatment.
Dolutegravir, Emtricitabine and Tenofovir Alafenamide are the key active components present in it.
DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE is not recommended for use in children under 12 years of age. Please consult your doctor in case of any concerns.
Taking more than the recommended dosage does not provide additional pain relief and can increase the risk of adverse effects.
Avoid consuming alcohol along with DOLUTEGRAVIR+EMTRICITABINE+TENOFOVIR ALAFENAMIDE as it could lead to adverse effects.
